Global Atrophic Scars Treatment Market Size, Share, Growth, and Forecast Report 2030
The value of the worldwide atrophic scars treatment market was around USD 23.62 billion in 2022. It is anticipated that this market will expand to approximately USD 47.19 billion by 2030, expanding at a compound annual growth rate (CAGR) of approximately 9.04% between the years 2023 and 2030.
Atrophic Scars Treatment Market: Overview
Scars on the skin that are created by the atrophying of tissue, such as fat and collagen, are called atrophic scars. These scars have a tendency to look sunken or depressed in the skin, and they can be produced by a variety of disorders, including acne, chickenpox, or injuries. The appearance of atrophic scars can have a devastating effect on a person’s sense of self-worth and confidence. There are many different types of treatment that can be used to combat atrophic scars while also encouraging the formation of new skin tissue that is both healthy and in good condition. The success of each technique may be contingent on a number of different aspects, and the road to recovery may look different for different patients.
For instance, the degree of severity of the scar as well as the amount of experience that the medical practitioner treating the ailment possesses are major factors that play a part in determining how successfully the problem can be treated. People may prefer to cure such ailments using home remedies, despite the fact that it is suggested that the condition be treated by licensed medical experts who are certified to do so.
Read Related:
https://www.zionmarketresearch.com/news/global-atrophic-scars-treatment-market
Atrophic Scars Treatment Market: Growth Drivers
Innovations in scar treatment methods are expected to be a primary growth driver for the market.
As a result of rising investments in the research and development of innovative scar treatment technologies, the global market for the treatment of atrophic scars is anticipated to expand in the coming years. In the past ten years, the healthcare industry has been through a period of remarkable change as a direct result of the rising demand for high-quality medical treatment and the significant reallocation of resources towards the enhancement of care provided to patients. An extensive study into the underlying causes of atrophic scars as well as other medical disorders, as well as the creation of target-oriented medical treatments or therapies, has played a significant role in allowing medical professionals to treat a wider spectrum of patients. This has been made possible as a direct result of the research that has been conducted.
Atrophic Scars Treatment Market: Segmentation
Distribution channel, product type, and geographic location are the primary factors used to segment the global market for atrophic scars treatment.
The pharmacies and drug stores sector accounts for the largest share of the global market, followed by hospitals, the online retail sector, dermatological clinics, and other outpatient care centers. The market for the treatment of atrophic scars experienced the largest growth rate in the clinics and dermatology centers sector in 2022. This is due to the fact that these facilities are staffed by highly trained medical specialists who have many years of both practical experience and theoretical knowledge in the field of treating skin-related illnesses. In addition, they have better access to essential testing and diagnostic medical equipment, and they provide a comprehensive variety of treatments, which includes the treatment of all types of scars.
Atrophic Scars Treatment Market: Regional Analysis
North America to continue its dominant growth streak
The global atrophic scars treatment market is expected to witness the highest growth in North America owing to the presence of an established and robust industry for skin care and treatment. Additionally, the population in this region and particularly in Canada and the US has a high awareness rate while the healthcare sector promotes proactive care. The US is home to some of the world’s most renowned dermatologists and people from across the globe travel to the country for skin-related conditions. Increasing research & development along with product innovation and the launch of advanced diagnostic or treatment devices further drives the regional market growth.
Atrophic Scars Treatment Market: Competitive Analysis
The global atrophic scars treatment market is led by players like :
Allergan (AbbVie)
Galderma
Merz Pharma
Cynosure
Syneron Candela
Lumenis
Cutera
Sciton
Alma Lasers
Sinclair Pharma
Suneva Medical
Johnson & Johnson
Bausch Health Companies
Revance Therapeutics
Endo International
Sanofi
Nestlé Skin Health
Merck & Co.
Smith & Nephew
Integra Lifesciences
Coloplast
Medtronic
Zimmer Biomet
Stryker
Misonix.
The global atrophic scars treatment market is segmented as follows:
By Distribution Channel
Pharmacies & Drug Stores
Hospitals
E-Commerce
Clinics & Dermatology Centers
By Product Type
Laser
Topical
Injectable
Surface Treatment
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Contact US
Zion Market Research
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL-FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
Read Also:
https://www.linkedin.com/pulse/global-clickstream-analytics-market-size-share-growth-michael-goode/
https://www.linkedin.com/pulse/clean-label-ingredients-market-size-share-trend-growth-rohit-patil/
